Global Recombinant Human Granulocyte Colony-Stimulating Market Growth 2024-2031

Report ID: 1332682 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Recombinant Human Granulocyte Colony-Stimulating by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Recombinant Human Granulocyte Colony-Stimulating by Country/Region, 2017, 2022 & 2028
    2.2 Recombinant Human Granulocyte Colony-Stimulating Segment by Type
        2.2.1 Lenograstim (Granocyte)
        2.2.2 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
        2.2.3 Others
    2.3 Recombinant Human Granulocyte Colony-Stimulating Sales by Type
        2.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2022)
        2.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Recombinant Human Granulocyte Colony-Stimulating Sale Price by Type (2017-2022)
    2.4 Recombinant Human Granulocyte Colony-Stimulating Segment by Application
        2.4.1 Chemotherapy Induced Neutropenia
        2.4.2 Before Blood Donation
        2.4.3 Stem Cell Transplants
        2.4.4 Others
    2.5 Recombinant Human Granulocyte Colony-Stimulating Sales by Application
        2.5.1 Global Recombinant Human Granulocyte Colony-Stimulating Sale Market Share by Application (2017-2022)
        2.5.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Recombinant Human Granulocyte Colony-Stimulating Sale Price by Application (2017-2022)
3 Global Recombinant Human Granulocyte Colony-Stimulating by Company
    3.1 Global Recombinant Human Granulocyte Colony-Stimulating Breakdown Data by Company
        3.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Annual Sales by Company (2020-2022)
        3.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Company (2020-2022)
    3.2 Global Recombinant Human Granulocyte Colony-Stimulating Annual Revenue by Company (2020-2022)
        3.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2020-2022)
        3.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Company (2020-2022)
    3.3 Global Recombinant Human Granulocyte Colony-Stimulating Sale Price by Company
    3.4 Key Manufacturers Recombinant Human Granulocyte Colony-Stimulating Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Recombinant Human Granulocyte Colony-Stimulating Product Location Distribution
        3.4.2 Players Recombinant Human Granulocyte Colony-Stimulating Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Recombinant Human Granulocyte Colony-Stimulating by Geographic Region
    4.1 World Historic Recombinant Human Granulocyte Colony-Stimulating Market Size by Geographic Region (2017-2022)
        4.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Annual Revenue by Geographic Region
    4.2 World Historic Recombinant Human Granulocyte Colony-Stimulating Market Size by Country/Region (2017-2022)
        4.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Annual Revenue by Country/Region
    4.3 Americas Recombinant Human Granulocyte Colony-Stimulating Sales Growth
    4.4 APAC Recombinant Human Granulocyte Colony-Stimulating Sales Growth
    4.5 Europe Recombinant Human Granulocyte Colony-Stimulating Sales Growth
    4.6 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Growth
5 Americas
    5.1 Americas Recombinant Human Granulocyte Colony-Stimulating Sales by Country
        5.1.1 Americas Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022)
        5.1.2 Americas Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022)
    5.2 Americas Recombinant Human Granulocyte Colony-Stimulating Sales by Type
    5.3 Americas Recombinant Human Granulocyte Colony-Stimulating Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Recombinant Human Granulocyte Colony-Stimulating Sales by Region
        6.1.1 APAC Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2017-2022)
        6.1.2 APAC Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2017-2022)
    6.2 APAC Recombinant Human Granulocyte Colony-Stimulating Sales by Type
    6.3 APAC Recombinant Human Granulocyte Colony-Stimulating Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Recombinant Human Granulocyte Colony-Stimulating by Country
        7.1.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022)
        7.1.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022)
    7.2 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Type
    7.3 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating by Country
        8.1.1 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022)
    8.2 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Type
    8.3 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Recombinant Human Granulocyte Colony-Stimulating
    10.3 Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating
    10.4 Industry Chain Structure of Recombinant Human Granulocyte Colony-Stimulating
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Recombinant Human Granulocyte Colony-Stimulating Distributors
    11.3 Recombinant Human Granulocyte Colony-Stimulating Customer
12 World Forecast Review for Recombinant Human Granulocyte Colony-Stimulating by Geographic Region
    12.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Forecast by Region
        12.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Forecast by Region (2023-2028)
        12.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Recombinant Human Granulocyte Colony-Stimulating Forecast by Type
    12.7 Global Recombinant Human Granulocyte Colony-Stimulating Forecast by Application
13 Key Players Analysis
    13.1 Amgen
        13.1.1 Amgen Company Information
        13.1.2 Amgen Recombinant Human Granulocyte Colony-Stimulating Product Offered
        13.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Amgen Main Business Overview
        13.1.5 Amgen Latest Developments
    13.2 Qilu Pharmaceutical
        13.2.1 Qilu Pharmaceutical Company Information
        13.2.2 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Offered
        13.2.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Qilu Pharmaceutical Main Business Overview
        13.2.5 Qilu Pharmaceutical Latest Developments
    13.3 Shijiazhuang Pharmaceutical
        13.3.1 Shijiazhuang Pharmaceutical Company Information
        13.3.2 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Offered
        13.3.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Shijiazhuang Pharmaceutical Main Business Overview
        13.3.5 Shijiazhuang Pharmaceutical Latest Developments
    13.4 Kyowa Hakko Kirin
        13.4.1 Kyowa Hakko Kirin Company Information
        13.4.2 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product Offered
        13.4.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Kyowa Hakko Kirin Main Business Overview
        13.4.5 Kyowa Hakko Kirin Latest Developments
    13.5 Gensci
        13.5.1 Gensci Company Information
        13.5.2 Gensci Recombinant Human Granulocyte Colony-Stimulating Product Offered
        13.5.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Gensci Main Business Overview
        13.5.5 Gensci Latest Developments
    13.6 Amoytop Biotech
        13.6.1 Amoytop Biotech Company Information
        13.6.2 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product Offered
        13.6.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Amoytop Biotech Main Business Overview
        13.6.5 Amoytop Biotech Latest Developments
    13.7 Hangzhou Jiuyuan
        13.7.1 Hangzhou Jiuyuan Company Information
        13.7.2 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product Offered
        13.7.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Hangzhou Jiuyuan Main Business Overview
        13.7.5 Hangzhou Jiuyuan Latest Developments
    13.8 Huaxin
        13.8.1 Huaxin Company Information
        13.8.2 Huaxin Recombinant Human Granulocyte Colony-Stimulating Product Offered
        13.8.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Huaxin Main Business Overview
        13.8.5 Huaxin Latest Developments
    13.9 Triprime
        13.9.1 Triprime Company Information
        13.9.2 Triprime Recombinant Human Granulocyte Colony-Stimulating Product Offered
        13.9.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Triprime Main Business Overview
        13.9.5 Triprime Latest Developments
    13.10 Sinovac
        13.10.1 Sinovac Company Information
        13.10.2 Sinovac Recombinant Human Granulocyte Colony-Stimulating Product Offered
        13.10.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Sinovac Main Business Overview
        13.10.5 Sinovac Latest Developments
    13.11 Zhaoke
        13.11.1 Zhaoke Company Information
        13.11.2 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product Offered
        13.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Zhaoke Main Business Overview
        13.11.5 Zhaoke Latest Developments
    13.12 Kawin
        13.12.1 Kawin Company Information
        13.12.2 Kawin Recombinant Human Granulocyte Colony-Stimulating Product Offered
        13.12.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Kawin Main Business Overview
        13.12.5 Kawin Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Recombinant Human Granulocyte Colony-Stimulating Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Recombinant Human Granulocyte Colony-Stimulating Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Lenograstim (Granocyte)
    Table 4. Major Players of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
    Table 5. Major Players of Others
    Table 6. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2022) & (KG)
    Table 7. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2022)
    Table 8. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2017-2022) & ($ million)
    Table 9. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2017-2022)
    Table 10. Global Recombinant Human Granulocyte Colony-Stimulating Sale Price by Type (2017-2022) & (USD/g)
    Table 11. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2022) & (KG)
    Table 12. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2022)
    Table 13. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2017-2022)
    Table 14. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2017-2022)
    Table 15. Global Recombinant Human Granulocyte Colony-Stimulating Sale Price by Application (2017-2022) & (USD/g)
    Table 16. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Company (2020-2022) & (KG)
    Table 17. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Company (2020-2022)
    Table 18. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Company (2020-2022) ($ Millions)
    Table 19. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Company (2020-2022)
    Table 20. Global Recombinant Human Granulocyte Colony-Stimulating Sale Price by Company (2020-2022) & (USD/g)
    Table 21. Key Manufacturers Recombinant Human Granulocyte Colony-Stimulating Producing Area Distribution and Sales Area
    Table 22. Players Recombinant Human Granulocyte Colony-Stimulating Products Offered
    Table 23. Recombinant Human Granulocyte Colony-Stimulating Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Geographic Region (2017-2022) & (KG)
    Table 27. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Geographic Region (2017-2022)
    Table 28. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 29. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Geographic Region (2017-2022)
    Table 30. Global Recombinant Human Granulocyte Colony-Stimulating Sales by Country/Region (2017-2022) & (KG)
    Table 31. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country/Region (2017-2022)
    Table 32. Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Country/Region (2017-2022) & ($ millions)
    Table 33. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country/Region (2017-2022)
    Table 34. Americas Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022) & (KG)
    Table 35. Americas Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2017-2022)
    Table 36. Americas Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022) & ($ Millions)
    Table 37. Americas Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2017-2022)
    Table 38. Americas Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2022) & (KG)
    Table 39. Americas Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2022)
    Table 40. Americas Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2022) & (KG)
    Table 41. Americas Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2022)
    Table 42. APAC Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2017-2022) & (KG)
    Table 43. APAC Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2017-2022)
    Table 44. APAC Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2017-2022) & ($ Millions)
    Table 45. APAC Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Region (2017-2022)
    Table 46. APAC Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2022) & (KG)
    Table 47. APAC Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2022)
    Table 48. APAC Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2022) & (KG)
    Table 49. APAC Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2022)
    Table 50. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022) & (KG)
    Table 51. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2017-2022)
    Table 52. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022) & ($ Millions)
    Table 53. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2017-2022)
    Table 54. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2022) & (KG)
    Table 55. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2022)
    Table 56. Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2022) & (KG)
    Table 57. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2022)
    Table 58. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2022) & (KG)
    Table 59. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country (2017-2022)
    Table 60. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2022) & ($ Millions)
    Table 61. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country (2017-2022)
    Table 62. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2022) & (KG)
    Table 63. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2022)
    Table 64. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2022) & (KG)
    Table 65. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2022)
    Table 66. Key Market Drivers & Growth Opportunities of Recombinant Human Granulocyte Colony-Stimulating
    Table 67. Key Market Challenges & Risks of Recombinant Human Granulocyte Colony-Stimulating
    Table 68. Key Industry Trends of Recombinant Human Granulocyte Colony-Stimulating
    Table 69. Recombinant Human Granulocyte Colony-Stimulating Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. Recombinant Human Granulocyte Colony-Stimulating Distributors List
    Table 72. Recombinant Human Granulocyte Colony-Stimulating Customer List
    Table 73. Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Region (2023-2028) & (KG)
    Table 74. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Forecast by Region
    Table 75. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 76. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Region (2023-2028)
    Table 77. Americas Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Country (2023-2028) & (KG)
    Table 78. Americas Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 79. APAC Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Region (2023-2028) & (KG)
    Table 80. APAC Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 81. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Country (2023-2028) & (KG)
    Table 82. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 83. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Country (2023-2028) & (KG)
    Table 84. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Type (2023-2028) & (KG)
    Table 86. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Type (2023-2028)
    Table 87. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 88. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Type (2023-2028)
    Table 89. Global Recombinant Human Granulocyte Colony-Stimulating Sales Forecast by Application (2023-2028) & (KG)
    Table 90. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share Forecast by Application (2023-2028)
    Table 91. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 92. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share Forecast by Application (2023-2028)
    Table 93. Amgen Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors
    Table 94. Amgen Recombinant Human Granulocyte Colony-Stimulating Product Offered
    Table 95. Amgen Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 96. Amgen Main Business
    Table 97. Amgen Latest Developments
    Table 98. Qilu Pharmaceutical Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors
    Table 99. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Offered
    Table 100. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 101. Qilu Pharmaceutical Main Business
    Table 102. Qilu Pharmaceutical Latest Developments
    Table 103. Shijiazhuang Pharmaceutical Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors
    Table 104. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Offered
    Table 105. Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 106. Shijiazhuang Pharmaceutical Main Business
    Table 107. Shijiazhuang Pharmaceutical Latest Developments
    Table 108. Kyowa Hakko Kirin Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors
    Table 109. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product Offered
    Table 110. Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 111. Kyowa Hakko Kirin Main Business
    Table 112. Kyowa Hakko Kirin Latest Developments
    Table 113. Gensci Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors
    Table 114. Gensci Recombinant Human Granulocyte Colony-Stimulating Product Offered
    Table 115. Gensci Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 116. Gensci Main Business
    Table 117. Gensci Latest Developments
    Table 118. Amoytop Biotech Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors
    Table 119. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product Offered
    Table 120. Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 121. Amoytop Biotech Main Business
    Table 122. Amoytop Biotech Latest Developments
    Table 123. Hangzhou Jiuyuan Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors
    Table 124. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product Offered
    Table 125. Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 126. Hangzhou Jiuyuan Main Business
    Table 127. Hangzhou Jiuyuan Latest Developments
    Table 128. Huaxin Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors
    Table 129. Huaxin Recombinant Human Granulocyte Colony-Stimulating Product Offered
    Table 130. Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 131. Huaxin Main Business
    Table 132. Huaxin Latest Developments
    Table 133. Triprime Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors
    Table 134. Triprime Recombinant Human Granulocyte Colony-Stimulating Product Offered
    Table 135. Triprime Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 136. Triprime Main Business
    Table 137. Triprime Latest Developments
    Table 138. Sinovac Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors
    Table 139. Sinovac Recombinant Human Granulocyte Colony-Stimulating Product Offered
    Table 140. Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 141. Sinovac Main Business
    Table 142. Sinovac Latest Developments
    Table 143. Zhaoke Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors
    Table 144. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product Offered
    Table 145. Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 146. Zhaoke Main Business
    Table 147. Zhaoke Latest Developments
    Table 148. Kawin Basic Information, Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base, Sales Area and Its Competitors
    Table 149. Kawin Recombinant Human Granulocyte Colony-Stimulating Product Offered
    Table 150. Kawin Recombinant Human Granulocyte Colony-Stimulating Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 151. Kawin Main Business
    Table 152. Kawin Latest Developments
List of Figures
    Figure 1. Picture of Recombinant Human Granulocyte Colony-Stimulating
    Figure 2. Recombinant Human Granulocyte Colony-Stimulating Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Recombinant Human Granulocyte Colony-Stimulating Sales Growth Rate 2017-2028 (KG)
    Figure 7. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Lenograstim (Granocyte)
    Figure 10. Product Picture of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
    Figure 11. Product Picture of Others
    Figure 12. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type in 2021
    Figure 13. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2017-2022)
    Figure 14. Recombinant Human Granulocyte Colony-Stimulating Consumed in Chemotherapy Induced Neutropenia
    Figure 15. Global Recombinant Human Granulocyte Colony-Stimulating Market: Chemotherapy Induced Neutropenia (2017-2022) & (KG)
    Figure 16. Recombinant Human Granulocyte Colony-Stimulating Consumed in Before Blood Donation
    Figure 17. Global Recombinant Human Granulocyte Colony-Stimulating Market: Before Blood Donation (2017-2022) & (KG)
    Figure 18. Recombinant Human Granulocyte Colony-Stimulating Consumed in Stem Cell Transplants
    Figure 19. Global Recombinant Human Granulocyte Colony-Stimulating Market: Stem Cell Transplants (2017-2022) & (KG)
    Figure 20. Recombinant Human Granulocyte Colony-Stimulating Consumed in Others
    Figure 21. Global Recombinant Human Granulocyte Colony-Stimulating Market: Others (2017-2022) & (KG)
    Figure 22. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2022)
    Figure 23. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application in 2021
    Figure 24. Recombinant Human Granulocyte Colony-Stimulating Revenue Market by Company in 2021 ($ Million)
    Figure 25. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Company in 2021
    Figure 26. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Geographic Region (2017-2022)
    Figure 27. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Geographic Region in 2021
    Figure 28. Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region (2017-2022)
    Figure 29. Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country/Region in 2021
    Figure 30. Americas Recombinant Human Granulocyte Colony-Stimulating Sales 2017-2022 (KG)
    Figure 31. Americas Recombinant Human Granulocyte Colony-Stimulating Revenue 2017-2022 ($ Millions)
    Figure 32. APAC Recombinant Human Granulocyte Colony-Stimulating Sales 2017-2022 (KG)
    Figure 33. APAC Recombinant Human Granulocyte Colony-Stimulating Revenue 2017-2022 ($ Millions)
    Figure 34. Europe Recombinant Human Granulocyte Colony-Stimulating Sales 2017-2022 (KG)
    Figure 35. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue 2017-2022 ($ Millions)
    Figure 36. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales 2017-2022 (KG)
    Figure 37. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue 2017-2022 ($ Millions)
    Figure 38. Americas Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2021
    Figure 39. Americas Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2021
    Figure 40. United States Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Canada Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Mexico Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Brazil Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 44. APAC Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Region in 2021
    Figure 45. APAC Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Regions in 2021
    Figure 46. China Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Japan Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 48. South Korea Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 50. India Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 51. Australia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Europe Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2021
    Figure 53. Europe Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2021
    Figure 54. Germany Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 55. France Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 56. UK Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Italy Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Russia Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Country in 2021
    Figure 60. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Country in 2021
    Figure 61. Egypt Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 62. South Africa Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Israel Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Turkey Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 65. GCC Country Recombinant Human Granulocyte Colony-Stimulating Revenue Growth 2017-2022 ($ Millions)
    Figure 66. Manufacturing Cost Structure Analysis of Recombinant Human Granulocyte Colony-Stimulating in 2021
    Figure 67. Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating
    Figure 68. Industry Chain Structure of Recombinant Human Granulocyte Colony-Stimulating
    Figure 69. Channels of Distribution
    Figure 70. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Recombinant Human Granulocyte Colony-Stimulating Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Recombinant Human Granulocyte Colony-Stimulating Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Recombinant Human Granulocyte Colony-Stimulating Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports